Meta-analysis of randomized control trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.
Work
Year: 2012
Type: article
Source: Journal of Clinical Oncology
Institutions Dana-Farber Brigham Cancer Center, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute
Cites:
Cited by: 2
Related to: 10
FWCI: 0.164
Citation percentile (by year/subfield): 53.83
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed